Peter Campochiaro, M.D.
Peter Campochiaro, M.D., is the Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist whose laboratory research studies ocular neovascularization and excessive vascular leakage, which occurs in age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. The clinical trial group under Campochiaro provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia.
Eye of the Needle
A retired patient visits our author, who is professor of ophthalmology and neuroscience at Johns Hopkins University School of Medicine, for help with his failing vision and learns why but a single treatment option exists for macular degeneration, a condition that affects 200 million people worldwide.